Table 1.
Criterium | Inclusion |
---|---|
Population | Children and adults with drug-induced HPL |
Intervention | Drug treatment known or suspected to induce HPL |
Comparator | Any or no comparator |
Outcomes | Clinical presentation, including symptoms and signs of druginduced HPL, such as reproductive dysfunction, sexual impairment, breast dysfunctions, abnormalities associated with chronic hypogonadism, behavioural and mood alterations |
Long-term complications of drug-induced HPL | |
Study design |
Interventional and non-interventional studies: • Non-interventional/observational studies (prospective, retrospective, cross-sectional studies) • Interventional studies (randomised and non-randomised clinical trials) |
HPL hyperprolactinaemia, PICOS populations, interventions and comparators, outcomes, and study design